https://www.selleckchem.com/pr....oducts/lonafarnib-sc
Trials.gov NCT04204109 on December 102,019 and with the National Committee on Health Research Ethics H-19087506 December 112,019 and the Danish Data Protection Agency P-2019-637 October 152,019. The intervention was registered at Clinical Trials.gov NCT04204109 on December 102,019 and with the National Committee on Health Research Ethics H-19087506 December 112,019 and the Danish Data Protection Agency P-2019-637 October 152,019.The clinical benefit of immune checkpoint inhibitory therapy (ICT) in advanced melanomas is limit
כמו
תגובה
לַחֲלוֹק
